產(chǎn)品展示
優(yōu)質(zhì)供應(yīng)
詳細(xì)內(nèi)容
艾美捷LKT Labs [脫-PRO2]-緩激肽 #B6808參數(shù)說(shuō)明:
Cas No.:80943-05-1
純度:≥95%
公式:C45H66N14O10
配方重量:963.12
溶解度:易溶于水。
儲(chǔ)存溫度:-20°C
LKT Labs [脫-PRO2]-緩激肽文獻(xiàn)引用:
Mamenko M, Zaika O, Pochynyuk O. Direct regulation of ENaC by bradykinin in the distal nephron. Implications for renal sodium handling. Curr Opin Nephrol Hypertens. 2014 Mar;23(2):122-9. PMID: 24378775.
Yu HS, Wang SW, Chang AC, et al. Bradykinin promotes vascular endothelial growth factor expression and increases angiogenesis in human prostate cancer cells. Biochem Pharmacol. 2014 Jan 15;87(2):243-53. PMID: 24225154.
Dong R, Xu X, Li G, et al. Bradykinin inhibits oxidative stress-induced cardiomyocytes senescence via regulating redox state. PLoS One. 2013 Oct 25;8(10):e77034. PMID: 24204728.
Feher A, Cassuto J, Szabo A, et al. Increased tissue angiotensin-converting enzyme activity impairs bradykinin-induced dilation of coronary arterioles in obesity. Circ J. 2013;77(7):1867-76. PMID: 23603844.
LKT Laboratories(LKT Labs)注于防癌抗癌特殊化學(xué)品研究和開發(fā)域。主要包括:癌癥藥物、藥物發(fā)現(xiàn)試劑盒、天然產(chǎn)物、廣泛的生命科學(xué)研究試劑、定制合成等。同時(shí)注研究用小分子的合成,純化和分離。主要應(yīng)用于癌癥和神經(jīng)科學(xué)等,包括蛋白激酶抑制劑、離子通道調(diào)節(jié)劑和激活劑等。艾美捷科技是LKT Labs的中國(guó)代理商,為科研工作者提供優(yōu)質(zhì)的產(chǎn)品與服務(wù)。
來(lái)源:https://www.amyjet.com/news/LKT-Laboratories-new.shtml